| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 |
|---|---|---|---|---|---|---|---|---|
Revenues | ||||||||
Service | ||||||||
16 | - | - | - | - | - | - | - | - |
Royalty | ||||||||
0 | - | - | - | - | - | - | - | - |
Total Revenues | ||||||||
17 | - | - | 0 | 0 | 0 | 0 | 54 | 0 |
Operating Expenses | ||||||||
Professional fees | ||||||||
- | - | - | - | 1,606 | 533 | 621 | 250 | 167 |
Salaries and office administrative fees | ||||||||
- | - | - | - | 1,628 | 1,075 | 666 | 666 | 672 |
Research and development | ||||||||
10,363 | 10,906 | 8,026 | 7,904 | 6,101 | 4,044 | 2,503 | 2,773 | 1,521 |
General and administrative | ||||||||
4,731 | 5,821 | 5,833 | 4,177 | 669 | 299 | 434 | 448 | 247 |
Sales and marketing | ||||||||
965 | 1,169 | 836 | 347 | - | - | - | - | - |
Impairment of patents | ||||||||
- | - | - | - | - | - | 350 | 0 | - |
Total Operating Expenses | ||||||||
16,060 | 17,897 | 14,696 | 12,430 | 10,005 | 5,952 | 4,575 | 4,138 | 2,608 |
Operating Loss | ||||||||
-16,042 | -17,897 | -14,696 | -12,430 | -10,005 | -5,952 | -4,575 | -4,083 | -2,608 |
Other Income (Expenses) | ||||||||
Grant income | ||||||||
155 | - | - | - | - | - | - | - | - |
Interest income | ||||||||
112 | - | - | - | - | - | - | - | - |
Other income | ||||||||
- | - | - | 545 | - | - | - | - | - |
Interest expense | ||||||||
-126 | -110 | 73 | 20 | - | - | - | - | - |
Grants received | ||||||||
- | - | - | - | - | 143 | 865 | 0 | - |
Other expenses | ||||||||
- | - | - | - | - | 14 | - | - | - |
Grants received | ||||||||
- | - | - | - | 146 | - | - | - | - |
Other expenses | ||||||||
- | - | - | - | 15 | - | - | - | - |
Other expenses | ||||||||
-196 | - | - | - | - | - | - | - | - |
Gain on derivative re-measurement | ||||||||
- | - | - | - | 339 | -2,420 | - | - | - |
Gain / (loss) on derivative re-measurement | ||||||||
- | - | - | - | - | - | 0 | - | - |
Total Other Expenses | ||||||||
- | - | - | 524 | 470 | -2,261 | 865 | - | - |
Total Other Income (Expenses) | ||||||||
-56 | -110 | - | - | - | - | - | - | - |
Provision for Income Taxes | ||||||||
- | - | - | 0 | -4 | 0 | 0 | 0 | 0 |
Net Loss | ||||||||
-16,099 | -18,008 | -14,769 | -11,905 | -9,530 | -8,213 | -3,710 | -4,083 | - |
Net Loss | ||||||||
- | - | - | - | - | - | - | - | -2,608 |
Other Comprehensive Income (Loss) | ||||||||
Foreign currency translation adjustments | ||||||||
-97 | 352 | - | - | - | - | - | - | - |
Net Comprehensive Loss | ||||||||
-16,197 | -17,655 | - | - | - | - | - | - | - |
Foreign currency translation adjustments | ||||||||
- | - | 63 | -109 | 19 | -44 | -25 | -38 | 43 |
Total Other Comprehensive Income (Loss) | ||||||||
- | - | - | -109 | - | - | - | - | - |
Total Other Comprehensive Income/(Loss) | ||||||||
- | - | - | - | 19 | -44 | -25 | -38 | 43 |
Net Comprehensive Loss | ||||||||
- | - | -14,705 | -12,014 | -9,510 | -8,257 | -3,735 | -4,121 | -2,565 |
Net Loss Per Share - Basic and Diluted attributable to VolitionRx Limited | ||||||||
-0.41 | -0.57 | -0.56 | -0.52 | -0.54 | -0.61 | -0.34 | -0.44 | -0.45 |
Weighted Average Shares Outstanding | ||||||||
Basic and Diluted | ||||||||
39,180 | 31,389 | 26,389 | 23,049 | 17,731 | 13,435 | 10,832 | 9,359 | - |
Weighted Average Shares Outstanding - Basic and Diluted | ||||||||
- | - | - | - | - | - | - | - | 5,768 |